Skip to main content
Fig. 5 | BMC Musculoskeletal Disorders

Fig. 5

From: Activation of FoxO1/SIRT1/RANKL/OPG pathway may underlie the therapeutic effects of resveratrol on aging-dependent male osteoporosis

Fig. 5

Resveratrol counters the altered inflammatory status in aged rats. a Serum high-sensitivity CRP levels in control (white column), aged (black column) and aged + resveratrol treated (grey column) groups. b Serum IL-1β levels in control (white column), aged (black column) and aged + resveratrol treated (grey column) groups. c Serum IL-6 levels in control (white column), aged (black column) and aged + resveratrol treated (grey column) groups. d Serum TNF-α levels in control (white column), aged (black column) and aged + resveratrol treated (grey column) groups. (Significant = p < 0.05, * significant when compared to the control group, significant when compared to the aged group. Number of rats = 10/group)

Back to article page